Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 6155-6161

  Scala, Giuseppe ^a,b   Chen, Xueni ^a   Liu, Weimin ^a   Telles, Jean Noel ^a   Cohen, Oren J ^a   Vaccarezza, Mauro ^a   Igarashi, Tatsu ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Università degli Studi di Catanzaro UOC Anestesia e Rianimazione   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY; PEPTIDE LIBRARY;

ANIMAL MODEL; ANTIGEN PURIFICATION; ANTIGENIC VARIATION; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; MONKEY; NONHUMAN; PRIORITY JOURNAL; SCREENING; VACCINE PRODUCTION; VIRUS NEUTRALIZATION;

EID: 0033563267     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681.
2. Burton, D. R. 1997. A vaccine for HIV type 1: the antibody perspective. Proc. Natl Acad. Sci. USA 94:10018.
3. Girard, M., F. Barre-Sinoussi, and E. van der Ryst. 1996. Vaccination of chimpanzees against HIV-1. Antibiot. Chemother. 48:121.
4. Burton, D. R., and D. C. Montefiori. 1997. The antibody response in HIV-1 infection. AIDS 11:S87.
5. Zolla-Pazner, S., M. Lubeck, S. Xu, S. Burda, R. J. Natuk, F. Sinangil, K. Steimer, R. C. Gallo, J. W. Eichberg, T. Matthews, and M. Robert-Guroff. 1998. Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees. J. Virol. 72:1052.
6. Eichberg, J. W., K. K. Murthy, R. H. Ward, and A. M. Prince. 1992. Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG. AIDS Res. Hum. Retroviruses 8:1515.
7. Emini, E. A., W. A. Schleif, J. H. Nunberg, A. J. Conley, Y. Eda, S. Tokiyoshi, S. D. Putney, S. Matsushita, K. E. Cobb, C. M. Jett, et al. 1992. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 355:728.
8. Gauduin, M. C., P. W. Parren, R. Weir, C. F. Barbas, D. R. Burton, and R. A. Koup. 1997. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat. Med. 3:1389.
9. Mascola, J. R., M. K. Louder, T. C. VanCott, C. V. Sapan, J. S. Lambert, L. R. Muenz, B. Bunow, D. L. Birx, and M. L. Robb. 1997. Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12. J. Virol. 71:7198.
10. Burton, D. R., and J. P. Moore. 1998. Why do we not have an HIV vaccine and how can we make one? Nat. Med. 4:495.
11. Heilman, C. A., and D. Baltimore. 1998. HIV vaccines: where are we going? Nat. Med 4:532.
12. Boots, L. J., P. M. McKenna, B. A. Arnold, P. M. Keller, M. K. Gomy, S. Zolla-Pazner, J. E. Robinson, and A. J. Conley. 1997. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries. AIDS Res. Hum. Retroviruses 13:1549.
13. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648.
14. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705.
15. Lewis, J., P. Balfe, C. Arnold, S. Kaye, R. S. Tedder, and J. A. McKeating. 1998. Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants. J. Virol. 72:8943.
16. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein, C. Fox, L. K. Schrager, et al. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209.
17. Felici, F., L. Castagnoli, A. Musacchio, R. Jappelli, and G. Cesareni. 1991. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J. Mol. Biol. 222:301.
18. Luzzago, A., F. Felici, A. Tramontane, A. Pessi, and R. Cortese. 1993. Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene 128:51.
19. Prezzi, C., M. Nuzzo, A. Meola, P. Delmastro, G. Galfre, R. Cortese, A. Nicosia, and P. Monaci. 1996. Selection of antigenic and immunogenic mimics of hepa-titis C virus using sera from patients. J. Immunol. 156:4504.
20. Montefiori, D. C., W. E. Robinson, Jr., S. S. Schuffman, and W. M. Mitchell. 1988. Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microater infection assay. J. Clin. Microbiol. 26:231.
21. Montefiori, D. C., R. G. Collman, T. R. Fouts, J, Y. Zhou, M. Bilska, J. A. Hoxie, J. P. Moore, and D. P. Bolognesi. 1998. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J. Virol. 72:1886.
22. Montefiori, D. C., G. Pantaleo, L. M. Fink, J. T. Zhou, J. Y. Zhou, M. Bilska, G. D. Miralles, and A. S. Fauci. 1996. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term non-progressors. J. Infect. Dis. 173:60.
23. Zhu, T., N. Wang, A. Carr, S. Wolinsky, and D. D. Ho. 1995. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconverter. J. Virol. 69:1324.
24. Shapshak, P., I. Nagano, K. Xin, W. Bradley, C. B. McCoy, N. C. Sun, R. V. Stewart, M. Yoshioka, C. Petito, K. Goodkin, et al. 1995. HIV-1 heterogeneity and cytokines: neuropathogenesis. Adv. Exp. Med. Biol. 373:225.
25. Vanden Haesevelde, M., J. L. Decourt, R. J. De Leys, B. Vanderborght, G. van der Groen, H. van Heuverswijn, and E. Saman. 1994. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J. Virol. 68:1586.
26. Cotropia, J., K. E. Ugen, S. Kliks, K. Broliden, P. A. Broliden, J. A. Hoxie, V. Srikantan, W. V. Williams, and D. B. Weiner. 1996. A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 12:221.
27. Meola, A., P. Delmastro. P. Monaci, A. Luzzago, A. Nicosia, F. Felici, R. Cortese, and G. Galfre. 1995. Derivation of vaccines from mimotopes: immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J. Immunol. 154:3162.
28. Shibata, R., C. Siemon, S. C. Czajak, R. C. Desrosiers, and M. A. Martin. 1997. Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. J. Virol. 71:8141.
29. Igarashi, T., Y. Ami, H. Yamamoto, R. Shibata, T. Kuwata, R. Mukai, K. Shinohara, T. Komatsu, A. Adachi, and M. Hayami. 1997. Protection of monkeys vaccinated with vpr-and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine. J. Gen. Virol. 78:985.
30. Miller, C. J., M. B. McChesney, X. Lu, P. J. Dailey, C. Chutkowski, D. Lu, P. Brosio, B. Roberts, and Y. Lu. 1997. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71:1911.
31. Simon, F., P. Mauclere, P. Roques, I. Loussert-Ajaka, M. C. Muller-Trutwin, S. Saragosti, M. C. Georges-Courbot, F. Barre-Sinoussi, and F. Brun-Vezinet. 1998. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 4:1032.
32. Cortese, R., P. Monaci, A. Luzzago, C. Santini, F. Bartoli, I. Cortese, P. Fortugno, G. Galfre, A. Nicosia, and F. Felici. 1996. Selection of biologically active peptides by phage display of random peptide libraries. Curr. Opin. Biotechnol. 7:616.
33. Reitter, J. N., R. E. Means, and R. C. Desrosiers. 1998. A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4:679.
34. Shibata, R., M. Kawamura, H. Sakai, M. Hayami, A. Ishimoto, and A. Adachi. 1991. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65:3514.
35. Puntoriero, G., A. Meola, A. Lahm, S. Zucchelli, E. Bruno Bruni, R. Tafi, M. Pezzanera, M. U. Mondelli, R. Cortese, A. Tramontane, G. Galfre, and A. Nicosia. 1998. Toward a solution for hepatitis C virus hypervaliability: mimolopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J. 17:3521.
36. Galfre, G., P. Monaci, A. Nicosia, A. Luzzago, F. Felici, and R. Cortese. 1996. Immunization with phage-displayed mimotopes. Methods Enzymol. 267:109.
37. Delmastro, P., A. Meola, P. Monaci, R. Cortese, and G. Galfre. 1997. Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration. Vaccine 15:1276.
38. Shibata, R., F. Maldarelli, C. Siemon, T. Matano, M. Parta, G. Miller, T. Fredrickson, and M. A. Martin. 1997. Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing. J. Infect. Dis. 176:362.